This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
AI drug discovery company Exscientia Ltd. raised $26mm in its Series B financing round from new investors Celgene and specialist health care investor GT Healthcare Capital Partners along with returning backer Evotec. The company plans to use the proceeds to scale its pipeline and advance selected programs toward the clinic. Exscientia expects its first programs driven by AI to be IND-ready within the next year.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?